Inventor · disambiguated record
Michael Berlin
Also filed as: BERLIN MICHAEL · BERLIN MICHAEL M
18 granted patents·23 pending applications·65 citations·filing 2016–2025
92Inventor score
Top patents by PatentIndex Score
41 records- 0197US10730870B2Compounds and methods for the enhanced degradation of targeted proteinsARVINAS INC·Filed 2016·Granted Aug 4, 2020·25 cites·22 claims
- 0296US10772962B2Compounds and methods for the targeted degradation of bromodomain-containing proteinsARVINAS INC·Filed 2016·Granted Sep 15, 2020·15 cites·23 claims
- 0395US12053469B2Indazole based compounds and associated methods of useARVINAS OPERATIONS INC·Filed 2021·Granted Aug 6, 2024·6 cites·6 claims
- 0495US11981683B2Indazole based compounds and associated methods of useARVINAS OPERATIONS INC·Filed 2022·Granted May 14, 2024·5 cites·2 claims
- 0590US11858940B2Selective modulators of mutant LRRK2 proteolysis and associated methods of useARVINAS OPERATIONS INC·Filed 2021·Granted Jan 2, 2024·2 cites·12 claims
- 0689US11191741B2Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptideARVINAS OPERATIONS INC·Filed 2017·Granted Dec 7, 2021·3 cites·13 claims
- 0789US2025034096A1Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 0887US11912699B2Tau-protein targeting compounds and associatedARVINAS OPERATIONS INC·Filed 2020·Granted Feb 27, 2024·2 cites·21 claims
- 0985US11707452B2Modulators of alpha-synuclein proteolysis and associated methods of useARVINAS OPERATIONS INC·Filed 2019·Granted Jul 25, 2023·2 cites·19 claims
- 1085US11427548B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2019·Granted Aug 30, 2022·2 cites·15 claims
- 1185US2025228944A1Compounds and methods for the targeted degradation of bromodomain-containing proteinsARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 1284US11512083B2Compounds and methods for the enhanced degradation of targeted proteinsARVINAS OPERATIONS INC·Filed 2020·Granted Nov 29, 2022·1 cites·17 claims
- 1383US11458123B2Tau-protein targeting PROTACs and associated methods of useARVINAS INC·Filed 2017·Granted Oct 4, 2022·2 cites·16 claims
- 1482US2025223265A1Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 1580US12171831B2Compounds and methods for the targeted degradation of bromodomain- containing proteinsARVINAS OPERATIONS INC·Filed 2022·Granted Dec 24, 2024·0 cites·14 claims
- 1679US12441708B2Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2022·Granted Oct 14, 2025·0 cites·20 claims
- 1779US2024382599A1Egfr proteolysis targeting chimeric molecules and associated methods of useARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 1878US12264157B2Compounds and methods for the enhanced degradation of targeted proteinsARVINAS OPERATIONS INC·Filed 2022·Granted Apr 1, 2025·0 cites·24 claims
- 1978US2025313547A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2025·Application pending·0 cites
- 2077US2025360219A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2025·Application pending·0 cites
- 2176US2024059686A1Compounds and methods for the targeted degradation of the androgen receptorARVINAS OPERATIONS INC·Filed 2022·Application pending·0 cites
- 2274US2025114356A1Indazole based compounds and associated methods of useARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 2374US2021040044A1Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2020·Application pending·0 cites
- 2473US12473294B2Selective modulators of mutant LRRK2 proteolysis and associated methods of useARVINAS OPERATIONS INC·Filed 2023·Granted Nov 18, 2025·0 cites·11 claims
- 2572US2024325547A1Modulators of bcl6 proteolysis and associated methods of useARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 2671US2024076295A1Brm targeting compounds and associated methods of useARVINAS OPERATIONS INC·Filed 2023·Application pending·0 cites
- 2769US11554171B2Compounds and methods for the targeted degradation of bromodomain-containing proteinsARVINAS OPERATIONS INC·Filed 2020·Granted Jan 17, 2023·0 cites·16 claims
- 2868US2020155690A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2020·Application pending·0 cites
- 2968US2020155689A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2020·Application pending·0 cites
- 3066US11857519B2Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptideARVINAS OPERATIONS INC·Filed 2021·Granted Jan 2, 2024·0 cites·16 claims
- 3166US2022162163A1Alanine-based modulators of proteolysis and associated methods of useARVINAS OPERATIONS INC·Filed 2022·Application pending·0 cites
- 3265US2018228907A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS INC·Filed 2018·Application pending·0 cites
- 3365US2023086457A1Tau-protein targeting protacs and associated methods of useARVINAS OPERATIONS INC·Filed 2022·Application pending·0 cites
- 3463US2024365736A1Compositions and methods for targeted degradation of proteins in a plant cellOERTH BIO LLC·Filed 2022·Application pending·0 cites
- 3562US2025064945A1Brm targeting compounds and associated methods of useARVINAS OPERATIONS INC·Filed 2022·Application pending·0 cites
- 3660US2018215731A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS INC·Filed 2018·Application pending·0 cites
- 3759US2025059198A1Brm degrading compounds and associated methods of useARVINAS OPERATIONS INC·Filed 2022·Application pending·0 cites
- 3856US2018346461A1Compounds and methods for the targeted degradation of androgen receptorARVINAS INC·Filed 2018·Application pending·0 cites
- 3953US12310975B2Modulators of BCL6 proteolysis and associated methods of useARVINAS OPERATIONS INC·Filed 2020·Granted May 27, 2025·0 cites·5 claims
- 4052US2019300521A1Brm targeting compounds and associated methods of useARVINAS OPERATIONS INC·Filed 2019·Application pending·0 cites
- 4145US2017037004A1Alanine-based modulators of proteolysis and associated methods of useARVINAS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Berlin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →